| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $660K | -4.5% |
| Cost of Revenue | $716K | +32.0% |
| Gross Profit | -$56K | -138.0% |
| R&D Expense | $525K | +508.3% |
| SG&A Expense | $2.8M | +101.8% |
| Interest Expense | $105K | +166.7% |
| Net Income | -$5.7M | -75.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.6M | +4404.3% |
| Accounts Receivable | $110K | +154.1% |
| Inventory | $95K | -65.6% |
| Current Assets | $4.2M | +558.2% |
| Total Assets | $4.7M | +468.9% |
| Current Liabilities | $600K | -2.7% |
| Total Liabilities | $665K | +7.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.2M | -165.6% |
| Capital Expenditures | $122K | +484.9% |
| Investing Cash Flow | -$220K | -85.7% |
| Financing Cash Flow | $7.0M | +402.1% |
| Free Cash Flow | -$3.3M | -170.9% |
| Stockholders' Equity |
| $4.0M |
| +1839.3% |